Matching of controls may lead to biased estimates of specificity in the evaluation of cancer screening tests
- PMID: 23257151
- DOI: 10.1016/j.jclinepi.2012.09.008
Matching of controls may lead to biased estimates of specificity in the evaluation of cancer screening tests
Abstract
Objectives: In the evaluation of cancer screening tests, cancer-free controls are often matched to cancer cases on factors such as sex and age. We assessed the potential merits and pitfalls of such matching using an example from colorectal cancer (CRC) screening.
Study design and setting: We compared sex and age distribution of CRC cases and cancer-free people undergoing screening colonoscopy in Germany in 2006 and 2007. We assessed specificity by sex and age of two immunochemical fecal occult blood tests (iFOBTs) in a study among screening colonoscopy participants conducted in the same years, and we assessed the expected impact of matching by sex and age on the validity of specificity estimates at various cut points.
Results: In the screening colonoscopy program, the proportion of men and mean age were 59.6% and 68.6 years among 10,324 CRC patients compared with 45.6% and 64.7 years, respectively, among 997,490 cancer-free participants. The specificity of the iFOBTs was higher among women than among men and decreased with age. Matching of cancer-free controls by age and sex would have led to the underestimation of specificity at all cut points assessed.
Conclusion: In the evaluation of cancer screening tests, matching of controls may lead to biased estimates of specificity.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
Interval cancers after negative colonoscopy: population-based case-control study.Gut. 2012 Nov;61(11):1576-82. doi: 10.1136/gutjnl-2011-301531. Epub 2011 Dec 26. Gut. 2012. PMID: 22200840
-
Prevalence of colorectal cancer and its precursor lesions in symptomatic and asymptomatic patients undergoing total colonoscopy: results of a large prospective, multicenter, controlled endoscopy study.Eur J Gastroenterol Hepatol. 2013 May;25(5):556-61. doi: 10.1097/MEG.0b013e32835d1ef4. Eur J Gastroenterol Hepatol. 2013. PMID: 23283303
-
Expected reduction of colorectal cancer incidence within 8 years after introduction of the German screening colonoscopy programme: estimates based on 1,875,708 screening colonoscopies.Eur J Cancer. 2009 Jul;45(11):2027-33. doi: 10.1016/j.ejca.2009.02.017. Epub 2009 Mar 14. Eur J Cancer. 2009. PMID: 19289271
-
Evidence for colorectal cancer screening.Best Pract Res Clin Gastroenterol. 2010 Aug;24(4):417-25. doi: 10.1016/j.bpg.2010.06.005. Best Pract Res Clin Gastroenterol. 2010. PMID: 20833346 Review.
-
[Colorectal cancer screening: evidence and implementation].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Mar;57(3):302-6. doi: 10.1007/s00103-013-1911-2. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014. PMID: 24562704 Review. German.
Cited by
-
Risk-Predictive and Diagnostic Biomarkers for Colorectal Cancer; a Systematic Review of Studies Using Pre-Diagnostic Blood Samples Collected in Prospective Cohorts and Screening Settings.Cancers (Basel). 2021 Aug 31;13(17):4406. doi: 10.3390/cancers13174406. Cancers (Basel). 2021. PMID: 34503217 Free PMC article. Review.
-
Colorectal Cancer Screening Prevalence and Adherence for the Cancer Prevention Project of Philadelphia (CAP3) Participants Who Self-Identify as Black.Front Oncol. 2021 Jul 30;11:690718. doi: 10.3389/fonc.2021.690718. eCollection 2021. Front Oncol. 2021. PMID: 34395256 Free PMC article.
-
Multiplex screening of 275 plasma protein biomarkers to identify a signature for early detection of colorectal cancer.Mol Oncol. 2020 Jan;14(1):8-21. doi: 10.1002/1878-0261.12591. Epub 2019 Nov 13. Mol Oncol. 2020. PMID: 31652396 Free PMC article.
-
Development and validation of a panel of five proteins as blood biomarkers for early detection of colorectal cancer.Clin Epidemiol. 2017 Oct 31;9:517-526. doi: 10.2147/CLEP.S144171. eCollection 2017. Clin Epidemiol. 2017. PMID: 29184444 Free PMC article.
-
Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting.Clin Epigenetics. 2017 Mar 3;9:24. doi: 10.1186/s13148-017-0322-x. eCollection 2017. Clin Epigenetics. 2017. PMID: 28270869 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
